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Pathophysiology of Ascites Formation in Cirrhosis of the Liver 
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Summary 
Current concepts of the pathophysiology of 
ascites formation in cirrhosis of the liver have become more 
complex. Traditionally, the initiating event of renal sodium 
and water retention in cirrhosis was considered to be ascites 
formation ("underfilling" hypothesis) or primary renal 
dysfunction ("overflow" hypothesis). Changes in systemic, 
splanchnic and renal hemodynamics, as well as of volume 
regulating hormones observed in cirrhosis are compatible 
with a decrease in effective blood volume as suggested by 
the "underfilling" hypothesis. These changes, however, 
have been shown to precede ascites formation. This obser-
vation, together with the demonstration of an increase in 
total blood volume in cirrhosis prompted the "overflow" 
hypothesis. However, many studies are incompatible with 
this concept and, in addition, the agent causing primary 
renal sodium retention in cirrhosis still remains to be de-
fined. The recently proposed "vasodilation" hypothesis 
reconciles the most salient features of both theories, pro-
posing peripheral arterial vasodilation as the initiating 
event of decreased effective blood volume and renal 
sodium retention. Further studies are needed to elucidate 
the temporal relationship and more precisely define the 
character of hemodynamic, humoral and renal changes in 
cirrhosis of the liver. 
Key words 
Ascites formation - Liver cirrhosis — Under-
filling - Overflow — "Vasodilation" hypothesis - Hemody-
namics — Volume regulating hormones — Sodium retention 
The regulation of sodium and water homeosta-
sis has been a puzzling subject of investigation for many years 
(1). In particular the concepts of pathophysiology of volume 
regulation and ascites formation in cirrhosis of the liver have 
become more and more complex (2—8). Several hypotheses 
have been elaborated in an attempt to explain ascites forma-
tion in liver cirrhosis: the "underfilling", the "overflow" and, 
most recently, the "vasodilation" hypothesis (9). These con-
cepts will be discussed in this review, incorporating hormonal 
and hemodynamic changes in cirrhosis of the liver. 
The "underfilling" hypothesis 
The classical "underfilling" theory (10) pro-
posed that ascites formation decreases centrally "effective" 
blood volume (EBV), thus inducing hormonal changes, result-
ing in renal sodium retention (Fig. I): the cirrhotic liver pro-
duces less albumin, thus reducing plasma oncotic pressure. 
Hepatic venous outflow obstruction increases hydrostatic 
pressure in the portal circulation. These changes in Starling 
forces increase extravasation in the splanchnic circulation. 
Once the ability of the lymphatic system to return lymph to the 
circulation is exceeded, protein-rich fluid spills from the he-
patic sinusoids into the peritoneal cavity and ascites becomes 
overt (11, 12). Ascites formation, as well as the formation of 
arteriovenous shunts (13) and reduction of peripheral vascu-
lar resistance (14), reduces non-splanchnic plasma volume. 
This reduction in "effective" blood volume activates sodium-
retaining hormonal systems such as the renin-angiotensin-al-
dosterone system or the sympathetic nervous system, resulting 
in renal sodium retention. Owing to the above-mentioned 
pathophysiological changes the retained fluid cannot re-
plenish the reduced EBV, but contributes to ascites formation, 
thus creating a vicious circle. 
Some problems with this concept have been 
caused by the inability to clearly define and determine the "ef-
fective" blood volume. EBV has been introduced as an oper-
ational definition (15) of that part of the blood volume with an 
effect on receptors of the volume regulatory systems. To date it 
has not been unanimously agreed whether changes in this ef-
fective volume concern the arterial blood volume, the central 
blood volume, or both. In an attempt to quantitate EBV, it has 
been defined as total blood volume minus the volume of the 
portal circulation (16), or as the total intrathoracic blood 
volume (17). It has been shown that, despite an increase in 
total blood volume of up to 30% (17-20), EBV was reduced. 
Such changes were most marked in patients with ascites, while 
cirrhotic patients without ascites exhibited smaller increases in 
total blood volume and decreases in EBV as compared with 
controls. 
Since changes in total blood volume primarily 
influence the low-pressure system (for review see 21), an in-
fluence on the atrial volume receptors (22, 23) might be antici-
pated. However, recent data (17, 20) suggest normal vascular 
filling of the cardiac compartment, but diminished filling of 
the aorta in cirrhosis. Thus, baroreceptors of the high-pressure 
system (24, 25) might be of pre-eminent importance in sensing 
reductions in EBV. 
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A number of hemodynamic and hormonal 
changes, as well as effects of maneuvers replenishing EBV are 
compatible with the "underfilling" hypothesis: 
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Fig. 1 Concepts of ascites formation in liver cirrhosis 
Systemic hemodynamics: compared with con-
trols, patients without ascites, and more so patients with 
ascites, exhibit decreased arterial blood pressure, increased 
heart rate and increased cardiac output. As mentioned before, 
EBV is reduced despite an increase in total blood volume. Pe-
ripheral vascular resistance is decreased (17,26—28). 
Splanchnic hemodynamics: portal venous pres-
sure, splanchnic inflow, and azygos blood flow are increased 
in cirrhosis, and even more so in patients with ascites, whereas 
hepatic blood flow is reduced (17, 26-28). 
Renal hemodynamics: renal blood flow, renal 
perfusion pressure and glomerular filtration rate are 
decreased at increased renal arteriovenous shunts (29—31). 
Hormonal changes: with increasing decompen-
sation, cirrhotic patients exhibit an activation of the renin-
angiotensin-aldosterone system (28, 32, 33) and of the sympa-
thetic nervous system, as indicated by plasma norepinephrine 
concentration (33, 34). Stimulation of sympathetic nervous 
system activity could contribute to sodium retention by chang-
ing the pattern of renal perfusion towards juxtamedullary ne-
phrons (35), by direct effects on the tubular epithelium (36) or 
by stimulating renal renin secretion (37). 
Natriuretic hormones: the existence of a "third 
factor" (38, 39) has long been proposed. This substance, pre-
sumably a peptide with digoxin-like immunoreactivity (40), 
has not been clearly characterized and quantified so far, and 
the concept of a deficiency of this natriuretic hormone in 
patients with cirrhosis (41) has not yet been confirmed. Re-
cently, concentrations of digoxin-like immunoreactive sub-
stances have even been found to be increased in plasma and 
urine of patients with chronic liver disease (42). The first well-
defined natriuretic hormone, the atrial natriuretic factor 
(ANF), does not show reduced plasma concentrations in cir-
rhosis (for review see 2). However, plasma concentrations of 
ANF relative to plasma renin activity or to plasma aldosterone 
concentration are reduced in cirrhosis, and ANF release upon 
volume stimulation seems to be blunted in patients with ascites 
(32). Renal response to endogenously released ANF (32) or to 
exogenously administered ANF (43, 44) would seem to be re-
duced in patients with ascites, possibly due to changes in renal 
ANF receptors (45). 
Water retention might be due to non-osmotic 
stimulation of vasopressin (46). Interpretation of the impor-
tance of vasopressin is hampered by methodological prob-
lems: plasma concentrations of healthy subjects or of patients 
with cirrhosis following a water load, were often found to be 
below the sensitivity limit of radioimmunological detection 
(46, 47). Several observations indicate a minor role for vaso-
pressin in the volume retention of cirrhosis: basal plasma con-
centrations in cirrhosis were not increased (for review see 47); 
in non-ascitic patients, water excretion was reduced despite 
normal vasopressin concentrations (48); following central 
volume expansion by water immersion (47) or peri-
toneovenous shunting (49), massive diuresis ensued despite 
unchanged or only minimally reduced plasma vasopressin 
concentrations. 
The "underfilling" hypothesis suggests that 
ascites formation precedes renal sodium retention. The above-
mentioned hormonal and hemodynamic changes and the well 
known fact of sodium retention in non-ascitic patients are not 
compatible with this concept, and were the main reason for the 
search for alternative concepts. 
The "overflow" theory 
Lieberman observed normal or increased total 
blood volume in patients with cirrhosis and ascites, which was 
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no different from patients with spontaneous diuresis (16). He 
therefore proposed the "overflow" hypothesis of ascites for-
mation (50). This concept presumes a primary renal salt- and 
water-retention in cirrhosis, resulting in an increase in plasma 
volume; owing to the changes in Starling forces in the portal 
circulation, ascites secondarily becomes overt as an "over-
flow" from the intravascular space (Fig. 1) 
This concept of ascites formation was sup-
ported by the observation that renal sodium retention 
precedes ascites formation in a dog model of cirrhosis (51, 52). 
The significance of these data was, however, questioned on ac-
count of the possible nephrotoxicity of nitrosamine, which 
was used to induce cirrhosis, the short interval between 
sodium retention and ascites formation, and the rather low 
level of sodium retention (53). 
The idea of primary renal dysfunction in cir-
rhosis was supported by the observation of ascites in patients 
with compensated cirrhosis following administration of min-
eralocorticoids and thus lacking mineralocorticoid "escape" 
(54). This finding, however, would also be compatible with in-
creased renal tubular sensitivity to mineralocorticoids, a 
decreased release of natriuretic factors, or a decreased sensi-
tivity to these factors in cirrhosis. 
A problem with the "overflow" theory is the as 
yet unresolved question as to why the kidney should retain 
sodium in liver disease. Since splanchnic blood volume was 
found to be increased in cirrhosis, some hepatorenal reflex has 
been hypothesized to cause renal functional impairment, but 
has not been clearly demonstrated so far. 
Moreover, a number of observations are 
hardly compatible with the "overflow" theory: decreased 
mean arterial blood pressure, an increased heart rate, and acti-
vation of the renin-angiotensin-aldosterone (26, 32, 33) and of 
the sympathetic nervous system (33, 34) have been observed in 
cirrhotic patients without ascites. 
Since neither the "underfilling" nor the "over-
flow" concept can fully explain ascites formation in cirrhosis, 
a new concept has recently been introduced, the "vasodila-
tion" hypothesis (9). 
The "peripheral arterial vasodilation" 
hypothesis 
The vasodilation hypothesis supports the "un-
derfilling" theory with the concept of peripheral arterial va-
sodilation as the initiating event (1,9) (Fig. 1): peripheral arte-
rial vasodilation initiates a moderate decrease in effective arte-
rial blood volume, and, due to reduced cardiac preload, an 
increase in cardiac output. In a compensatory reaction the 
body increases the plasma concentration of renin, al-
dosterone, norepinephrine and vasopressin, resulting in mod-
erate renal vasoconstriction with sodium and water retention. 
The resulting expansion of plasma volume then reduces the ac-
tivation of sodium retaining hormonal systems to a normal 
level; this might explain plasma concentrations of renin, al-
dosterone, norepinephrine and vasopressin within the normal 
range, as observed in some patients without ascites (54-56). 
With increasing severity of cirrhosis, peripheral vasodilation 
and the subsequent decrease in EBV, even marked activation 
of sodium and volume retaining hormones cannot achieve re-
plenishment of effective blood volume. These changes, to-
gether with a decreased plasma oncotic pressure by hypoal-
buminemia, induce ascites formation. The "vasodilation" hy-
pothesis, which is compatible with most observations on renal, 
hemodynamic and hormonal changes in cirrhosis, is sup-
ported by some recent studies (34,57—59): water excretion was 
significantly augmented in hyponatremic patients with cirrho-
sis and ascites by head-out water immersion, inducing an in-
crease in central blood volume (58). Increase in peripheral 
vascular resistance by infusion of norepinephrine in the same 
patients induced a comparable diuresis. A combination of 
both maneuvers significantly increased mean arterial pressure 
as well as renal perfusion pressure and peripheral vascular re-
sistance, resulting in normalization of natriuresis and diuresis. 
The importance of a decrease in distal tubular 
sodium delivery, caused by hemodynamic and hormonal 
changes, for sodium retention in cirrhosis has been demon-
strated in another recently reported study (34): spironolactone 
treatment increased urinary sodium excretion as well as frac-
tional sodium excretion more markedly in a group of patients 
with ascites than in a group of patients without ascites. In these 
same patients water immersion augmented natriuresis more 
markedly than immersion without spironolactone pretreat-
ment. The effects of these maneuvers, as well as changes in 
hemodynamic and hormonal parameters were more pro-
nounced in the patients with ascites than in those without 
ascites. 
A close chronological relationship between a 
decrease in arterial pressure and the onset of hyperaldoster-
onism and sodium retention in the development of cirrhosis 
has recently been demonstrated in cirrhotic rats (59), lending 
further support to the "vasodilation" hypothesis. 
A number of factors may be responsible for the 
vasodilation in cirrhosis: arteriovenous shunts in the splanch-
nic circulation, but also in the skin and lungs may contribute to 
arterial underfilling and to the ensuing sodium retention (60— 
62). Several bioactive compounds have been thought to be in-
volved in the peripheral arterial, mainly splanchnic, vasodila-
tion and in the renal vasoconstriction in cirrhosis (for review 
see 5, 63, 64): endotoxins and platelet activating factor (65— 
57), kinines (68-70), endogenous opioid peptides (71), false 
neurotransmitters (72), leukotrienes (73), prostaglandins (74, 
75), substance P (76) and vasoactive intestinal peptide (77,78). 
Furthermore, increased circulating levels of norepinephrine 
might induce downregulation of beta-adrenergic receptors 
(79), thus causing desensitization to sympathetic nervous sys-
tem activity (80, 81). 
The return of the renin-aldosterone and of the 
sympathetic nervous system activation to normal levels in 
early cirrhosis, as postulated by the "vasodilation" theory, as 
well as the temporal relationship of hemodynamic and hor-
monal changes to sodium retention and ascites formation, re-
mains to be more clearly defined. Longitudinal studies may 
further elucidate this least well defined part of the "vasodila-
tion" theory. 
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